-
NUMBER OF INSIDER BUYING
(Last 12 Months)
1 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
4 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$166,024 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$243,259
Fate Therapeutics, Inc. Insider Transactions
Fate Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
| Sell | 2,447 @ $7.77 | $19,013 | 101,479 | 03/04/2024 | 03/05/2024 | ||
| Sell | 1,849 @ $5.00 | $9,245 | 103,926 | 01/29/2024 | 01/30/2024 | ||
|
TAHL CINDY
General Counsel and Secretary |
Sell | 10,874 @ $4.37 | $47,519 | 142,361 | 01/09/2024 | 01/10/2024 | |
|
Valamehr Bahram
Chief R&D Officer |
Sell | 11,271 @ $4.38 | $49,367 | 158,069 | 01/09/2024 | 01/10/2024 | |
|
Wolchko J Scott
CEO |
Sell | 14,391 @ $4.37 | $62,889 | 371,248 | 01/09/2024 | 01/10/2024 | |
| Sell | 7,028 @ $4.37 | $30,712 | 105,775 | 01/09/2024 | 01/10/2024 | ||
| Sell | 5,182 @ $3.66 | $18,966 | 112,803 | 01/02/2024 | 01/03/2024 | ||
|
Redmile Group, LLC
Director, 10 percent owner: |
Buy | 44,630 @ $3.72 | $166,024 | 13,180,388 | 12/26/2023 | 12/28/2023 | |
| Sell | 1,585 @ $3.50 | $5,548 | 117,985 | 12/18/2023 | 12/19/2023 | ||
|
TAHL CINDY
General Counsel and Secretary |
Sell | 24,363 @ $2.40 | $58,471 | 153,235 | 11/09/2023 | 11/13/2023 | |
| Sell | 4,718 @ $2.80 | $13,210 | 119,570 | 08/18/2023 | 08/21/2023 | ||
|
Xu Yuan
Director |
Sell | 632 @ $3.71 | $2,345 | 9,302 | 08/04/2023 | 08/07/2023 | |
|
Powl Brian T.
Chief Commercial Officer |
Sell | 3,854 @ $4.87 | $18,769 | 41,146 | 07/05/2023 | 07/06/2023 | |
| Sell | 5,182 @ $4.83 | $25,029 | 124,288 | 07/05/2023 | 07/06/2023 | ||
|
Xu Yuan
Director |
Sell | 3,460 @ $5.58 | $19,307 | 9,934 | 06/14/2023 | 06/15/2023 | |
|
Redmile Group, LLC
Director, 10 percent owner: |
Buy | 256,639 @ $6.18 | $1.59 M | 13,135,758 | 04/21/2023 | 04/21/2023 | |
|
Redmile Group, LLC
Director, 10 percent owner: |
Buy | 20,000 @ $5.99 | $119,800 | 12,879,119 | 04/20/2023 | 04/21/2023 | |
|
Chu Yu-Waye
Chief Medical Officer |
Sell | 215 @ $6.52 | $1,402 | 142,993 | 04/18/2023 | 04/19/2023 | |
|
Chu Yu-Waye
Chief Medical Officer |
Sell | 2,317 @ $6.58 | $15,246 | 140,676 | 04/18/2023 | 04/19/2023 | |
|
Redmile Group, LLC
Director, 10 percent owner: |
Buy | 25,700 @ $6.00 | $154,200 | 12,859,119 | 04/14/2023 | 04/17/2023 |
Fate Therapeutics, Inc. Frequently Asked Questions
-
Who is on Fate Therapeutics, Inc.'s Insider Roster?
The list of insiders at Fate Therapeutics, Inc. includes Dulac Edward J III, Redmile Group, LLC, Wolchko J Scott, Valamehr Bahram, TAHL CINDY.
-
How much insider selling is happening at Fate Therapeutics, Inc.?
Insiders have sold a total of 54,627 Fate Therapeutics, Inc. shares in the last 12 months for a total of 243,259 sold.
-
Which Fate Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Fate Therapeutics, Inc. shares in the last 12 months: Dulac Edward J III ($83,484), Wolchko J Scott ($62,889), Valamehr Bahram ($49,367), TAHL CINDY ($47,519),
-
How much insider buying is happening at Fate Therapeutics, Inc.?
Insiders have purchased a total of 44,630 Fate Therapeutics, Inc. shares in the last 12 months for a total of 166,024 sold.
-
Which Fate Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Fate Therapeutics, Inc. shares in the last 12 months: Redmile Group, LLC ($166,024),